David J Mauro is Chief Medical Officer of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 243,762 shares of RXRX, which is worth approximately $2.02 Million. The most recent transaction as insider was on May 15, 2024, when has been sold 867 shares (Class A Common Stock) at a price of $10.01 per share, resulting in proceeds of $8,678. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 244K
0.35% 3M change
27.82% 12M change
Total Value Held $2.02 Million

David J Mauro Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 15 2024
SELL
Payment of exercise price or tax liability
$8,678 $10.01 p/Share
867 Reduced 0.35%
243,762 Class A Common Stock
Feb 09 2024
SELL
Payment of exercise price or tax liability
$19,090 $10.09 p/Share
1,892 Reduced 0.77%
244,629 Class A Common Stock
Feb 09 2024
BUY
Grant, award, or other acquisition
-
55,808 Added 18.46%
246,521 Class A Common Stock
Jun 01 2023
BUY
Grant, award, or other acquisition
-
190,713 Added 50.0%
190,713 Class A Common Stock

Also insider at

PRLD
Prelude Therapeutics Inc Healthcare
CDAK
Codiak BioSciences, Inc. Healthcare
DJM

David J Mauro

Chief Medical Officer
Cambridge, MA

Track Institutional and Insider Activities on RXRX

Follow RECURSION PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Track Activities on RXRX